Trials / Unknown
UnknownNCT03600168
Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery
A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding After Open Liver Resection
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- 3-D Matrix Europe SAS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this post-market clinical follow-up study is to collect medical information on patients implanted with PuraStat®, according to each participating institution's procedures and standards of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PuraStat® | Synthetic haemostatic material |
Timeline
- Start date
- 2018-08-02
- Primary completion
- 2019-09-04
- Completion
- 2020-02-01
- First posted
- 2018-07-26
- Last updated
- 2019-09-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03600168. Inclusion in this directory is not an endorsement.